Flt3 ligand does not differentiate between Parkinsonian disorders.
Silajdzic, Edina LU ; Constantinescu, Radu ; Holmberg, Björn ; Björkqvist, Maria LU
and Hansson, Oskar
LU
(2014)
In Movement Disorders
29(10).
p.1319-1322
- Abstract
- Differential diagnosis of parkinsonian disorders is challenging because of overlapping symptoms, especially during early stages of disease. No validated biomarkers are available for early and accurate diagnosis of multiple system atrophy and other parkinsonian disorders. It has been reported that flt3 ligand levels in cerebrospinal fluid could clearly differentiate patients with Parkinson's disease from patients with multiple system atrophy, with 99% sensitivity and 95% specificity.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4581650
- author
- Silajdzic, Edina
LU
; Constantinescu, Radu
; Holmberg, Björn
; Björkqvist, Maria
LU
and Hansson, Oskar
LU
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Movement Disorders
- volume
- 29
- issue
- 10
- pages
- 1319 - 1322
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- pmid:25044107
- wos:000342164600046
- scopus:84908383699
- pmid:25044107
- ISSN
- 0885-3185
- DOI
- 10.1002/mds.25948
- language
- English
- LU publication?
- yes
- id
- e58bd86c-0d56-416e-bdda-0f1371f0236b (old id 4581650)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25044107?dopt=Abstract
- date added to LUP
- 2016-04-01 09:54:07
- date last changed
- 2023-08-30 12:40:35
@article{e58bd86c-0d56-416e-bdda-0f1371f0236b,
abstract = {{Differential diagnosis of parkinsonian disorders is challenging because of overlapping symptoms, especially during early stages of disease. No validated biomarkers are available for early and accurate diagnosis of multiple system atrophy and other parkinsonian disorders. It has been reported that flt3 ligand levels in cerebrospinal fluid could clearly differentiate patients with Parkinson's disease from patients with multiple system atrophy, with 99% sensitivity and 95% specificity.}},
author = {{Silajdzic, Edina and Constantinescu, Radu and Holmberg, Björn and Björkqvist, Maria and Hansson, Oskar}},
issn = {{0885-3185}},
language = {{eng}},
number = {{10}},
pages = {{1319--1322}},
publisher = {{John Wiley & Sons Inc.}},
series = {{Movement Disorders}},
title = {{Flt3 ligand does not differentiate between Parkinsonian disorders.}},
url = {{http://dx.doi.org/10.1002/mds.25948}},
doi = {{10.1002/mds.25948}},
volume = {{29}},
year = {{2014}},
}